These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2140367)

  • 1. High-performance liquid chromatographic assay for trimetrexate in human plasma.
    Bullen WW; Chang T; Whitfield LR
    J Chromatogr; 1990 Mar; 526(1):266-72. PubMed ID: 2140367
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay and preclinical pharmacologic studies with the experimental antitumor agent batracylin.
    Ames MM; Mathiesen DA
    J Chromatogr; 1989 Jul; 491(2):488-94. PubMed ID: 2808633
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of evodiamine in rat plasma: application to pharmacokinetic studies.
    Jeng KF; Lin YH; Lin LC; Chou CJ; Tsai TH; Chen CF
    J Chromatogr B Biomed Appl; 1995 Jun; 668(2):343-5. PubMed ID: 7581872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a high-performance liquid chromatography ultraviolet method for lapatinib quantification in human plasma.
    Escudero-Ortiz V; Pérez-Ruixo JJ; Valenzuela B
    Ther Drug Monit; 2013 Dec; 35(6):796-802. PubMed ID: 23942544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic determination of 2-[3'-(methoxycarbonylamino)-phenyl]-3-phenyl-6-methoxycarbon ylamino-4-(3H)-quinazolone (NSC-251635) in human serum.
    Brassinne C; Laduron C; Sculier JP; Coune A
    J Chromatogr; 1985 May; 339(2):445-50. PubMed ID: 4008587
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved chromatographic method for the determination of trimetrexate in urine.
    Tinsley PW; LaCreta FP
    J Chromatogr; 1990 Aug; 529(2):468-72. PubMed ID: 2146281
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology and toxicity of a potent "nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs.
    Weir EC; Cashmore AR; Dreyer RN; Graham ML; Hsiao N; Moroson BA; Sawicki WL; Bertino JR
    Cancer Res; 1982 May; 42(5):1696-702. PubMed ID: 6461409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 schedule.
    Stewart JA; McCormack JJ; Tong W; Low JB; Roberts JD; Blow A; Whitfield LR; Haugh LD; Grove WR; Lopez AJ
    Cancer Res; 1988 Sep; 48(17):5029-35. PubMed ID: 2970294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of plasma trimetrexate levels using gas chromatography-mass spectrometry with selected-ion monitoring.
    Stetson PL; Ensminger WD
    J Chromatogr; 1986 Nov; 383(1):69-76. PubMed ID: 2950125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome.
    Rogers P; Allegra CJ; Murphy RF; Drake JC; Masur H; Poplack DG; Chabner BA; Parrillo JE; Lane HC; Balis FM
    Antimicrob Agents Chemother; 1988 Mar; 32(3):324-6. PubMed ID: 2966610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer.
    Reece PA; Morris RG; Bishop JF; Olver IN; Raghavan D
    Cancer Res; 1987 Jun; 47(11):2996-9. PubMed ID: 2952262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of trimetrexate (NSC 352122) in monkeys.
    Balis FM; Lester CM; Poplack DG
    Cancer Res; 1986 Jan; 46(1):169-74. PubMed ID: 2933145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescein-methotrexate-based flow cytometric bioassay for measurement of plasma methotrexate and trimetrexate levels.
    Assaraf YG; Molina A; Schimke RT
    Anal Biochem; 1989 May; 178(2):287-93. PubMed ID: 2526605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokinetics.
    Lin JT; Cashmore AR; Baker M; Dreyer RN; Ernstoff M; Marsh JC; Bertino JR; Whitfield LR; Delap R; Grillo-Lopez A
    Cancer Res; 1987 Jan; 47(2):609-16. PubMed ID: 2947679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of NK611, a novel water-soluble derivative of etoposide, and its metabolite (DeNK611) in dog plasma by column-switching high performance liquid chromatography.
    Machida M; Tanaka S; Nakamori K
    Biomed Chromatogr; 1993; 7(2):82-5. PubMed ID: 8485379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of pelanserin in human plasma by high-performance liquid chromatography with amperometric detection.
    Flores-Murrieta FJ; Castañeda-Hernández G; Hong E
    J Chromatogr; 1990 Jun; 528(2):501-8. PubMed ID: 2384588
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlates of severe or life-threatening toxic effects from trimetrexate.
    Grem JL; Ellenberg SS; King SA; Shoemaker DD
    J Natl Cancer Inst; 1988 Oct; 80(16):1313-8. PubMed ID: 2971817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks.
    Fanucchi MP; Walsh TD; Fleisher M; Lokos G; Williams L; Cassidy C; Vidal P; Chou TC; Niedzwiecki D; Young CW
    Cancer Res; 1987 Jun; 47(12):3303-8. PubMed ID: 2953412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of trimetrexate in combination with cisplatin.
    Hudes GR; LaCreta F; Walczak J; Tinsley P; Litwin S; Comis RL; O'Dwyer PJ
    Cancer Res; 1991 Jun; 51(12):3080-7. PubMed ID: 1828188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Pappo A; Dubowy R; Ravindranath Y; Alvarado C; Rao S; Whitehead VM; Vega R; Kamen B; Vietti T
    J Natl Cancer Inst; 1990 Oct; 82(20):1641-2. PubMed ID: 2145440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.